DOTA-GPC3 targeting peptide 2

Overview

DOTA-GPC3 targeting peptide 2 (Sequence 30) is a RDC peptide targeting GPC3 , with K d of 0.3 nM. DOTA-GPC3 targeting peptide 2 is composed of DOTA and GPC3 targeting peptide 2. DOTA-GPC3 targeting peptide 2 can be labeled with radioactive elements.

Application

Products | Products > Peptides | Products > Disease Areas > Cancer | Products > Signaling Pathways > Antibody-Drug Conjugate/ADC Related | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Radionuclide-Drug Conjugates (RDCs) | Products > Signaling Pathways > Glycoprotein VI

Product Information

• Catalog No.: HY-W1124925
• CAS No.: 3066439-94-6
• Molecular Formula: C107H145N21O29S
• Molecular Weight: 2221.48
• Purity: 98.83%
• Storage: -20°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Availability: In-stock

Source

Original product source